Sophie Béliard

Inserm FR

0000-0002-6000-5028

138

Publications

2,561

Citations

H-Index

i10-Index

3.71

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Safety and effectiveness in an uncontrolled setting of glucagon‐like‐peptide‐1 receptor agonists in patients with familial partial lipodystrophy: Real‐life experience from a national reference network OA

Sophie Lamothe, Inès Belalem, M. Vantyghem, Estelle Nobécourt, Héléna Mosbah - Diabetes, obesity and metabolism, 2025

Cited by 8 Semantic Scholar

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) OA

H. Mosbah, B. Donadille, C. Vatier, S. Janmaat, M. Atlan - Orphanet Journal of Rare Diseases, 2022

Cited by 21 Semantic Scholar

Research Topics

Lipoproteins and Cardiovascular Health (69) Diabetes, Cardiovascular Risks, and Lipoproteins (35) Lipid metabolism and disorders (21) Cancer, Lipids, and Metabolism (17) Cholesterol and Lipid Metabolism (12)

Affiliations

Institut National de la Recherche Agronomique

MA 2018 - 2016

Inserm

FR 2025 - 2011

Aix-Marseille Université

FR 2025 - 2009

Sorbonne Université

FR 2022 - 2012

Assistance Publique Hôpitaux de Marseille

FR 2024 - 2012

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Sophie Béliard

Publication & Citation Trends

Publications

Safety and effectiveness in an uncontrolled setting of glucagon‐like‐peptide‐1 receptor agonists in patients with familial partial lipodystrophy: Real‐life experience from a national reference network OA

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) OA

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back